Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Vantive - Spin Off or Sell Off ?
View:
Post by gebremeskel on Mar 04, 2024 11:16am

Vantive - Spin Off or Sell Off ?

FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): March 4, 2024 
 
Baxter International Inc
............
 
Item 7.01 Regulation FD Disclosure.
 
On March 4, 2024, Baxter International Inc. (“Baxter”) provided an update on the planned separation of its Kidney Care business. Consistent with Baxter’s commitment to evaluate strategic options in the interest of maximizing stockholder value, Baxter disclosed that it has been in recent discussions with select private equity investors to explore a potential sale of the Kidney Care asset in lieu of the proposed spinoff of that business. No final decision on the separation structure has been made and Baxter continues to make progress on the previously announced proposed spinoff of the Kidney Care business. Regardless of the separation structure ultimately selected, Baxter has expressed its commitment to separating the Kidney Care business in the second half of 2024.
 
Comment by palinc2000 on Mar 04, 2024 12:34pm
No impact on the Rights and Obligations  under the Amended Agreement between Baxter and Spectral  
Comment by BlueJays9293 on Mar 04, 2024 12:42pm
Wow, incredible research G-unit!  In my opinion this has the potential of removing the main obstacle that Baxter/Vantive faces in buying Spectral for $1B+, and that is that their debt raios are so high that they have to be really cautious with big expendidures.  Blackrock currently owns 59.7 million shares of Baxter and therefore I think there is a really good chance that they will be ...more  
Comment by JohnnyCashMoney on Mar 04, 2024 3:24pm
My mom has 10 trillion in asp cents. Shel will bring this sucker to ,55
Comment by Spamme54321 on Mar 04, 2024 5:24pm
See how these pumpers work, they keep dangling the carrot. Not like anything posted on this board is going to move the stock. Give it a break MercedesLadyBoy or BlueJerkOff or whatever you want to call yourself. Now Blackrocks going to buy us LOL,,, Maybe Bill Gates will take us private too. Keep the Delusional fantasies coming good for a laugh
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities